Serological antibody tests to detect active tuberculosis are inaccurate and not cost-effective

Despite being widely available for sale in low-and-middle income countries, commercial serological tests used to detect active tuberculosis (by identifying antibodies to the tuberculosis-causing bacterium in a blood sample) do not accurately diagnose TB and, furthermore, often test positive when the patient does not have TB (false positive) and test negative when the patient actually has TB (false negative). In addition, as shown in India, the use of such tests is not cost effective as compared to other tests available for TB.

These findings from two studies led by Madhukar Pai from McGill University and Montreal Chest Institute in Montreal, Canada, and published in this week's , formed the basis of a policy issued by the (WHO) on 20 July 2011 advising against the use of currently available serological tests for the diagnosis of tuberculosis. WHO recommended: "These tests should not be used in individuals suspected of active pulmonary or extra-pulmonary TB, irrespective of their ." The WHO policy strongly encourages further targeted research to identify new tests for TB diagnosis and alternative serological tests which would need to have much improved accuracy.

In the first article with Karen Steingart of the University of Washington, Seattle, USA as first author, the authors report searching the literature for relevant studies evaluating the accuracy of commercial serological tests. In their systematic review, they report that the sensitivity of serological tests (the proportion of patients with confirmed TB with a positive serological test), ranged from 0% to 100% and their specificities (the proportion of patients who did not have confirmed TB with a negative serological test) ranged from 31% to 100%. For extrapulmonary tuberculosis ( affecting parts of the body other than the lungs), sensitivities and specificities for each test also varied greatly, ranging from 0% to 100% and 59% to 100%, respectively. The authors found that, overall, the quality of evidence regarding diagnostic accuracy of serological tests was very low for both pulmonary and extrapulmonary tuberculosis.

The authors conclude: "Despite expansion of the literature since 2006, commercial serological tests continue to produce inconsistent and imprecise estimates of sensitivity and specificity."

In an associated study with David Dowdy of Johns Hopkins University, Baltimore, USA as first author, the authors analyzed the cost-effectiveness of TB serological tests from the perspective of tuberculosis control in India, compared to other diagnostic tests. They found that if used as an initial test for tuberculosis in India, serology would result in more DALYs (years of healthy life lost because of premature death or disability), more secondary infections, and more false-positive diagnoses than sputum smear microscopy while increasing costs per patient to the Indian tuberculosis control sector.

The authors conclude: "In India, sputum smear microscopy remains the most cost-effective diagnostic test available for active TB; efforts to increase access to quality-assured microscopy should take priority." Where quality microscopy is available, WHO-endorsed tests such as liquid cultures should be introduced to improve TB diagnosis.

More information: www.who.int/tb/features_archive/20july11_end_to_inaccurate_tb_blood_tests/en/index.html

add to favorites email to friend print save as pdf

Related Stories

New test quickly ID's active TB in smear-negative patients

Sep 23, 2009

Active tuberculosis can be rapidly identified in patients with negative sputum tests by a new method, according to European researchers. Active tuberculosis (TB) is the seventh-leading cause of death worldwide, and while ...

WHO: Blood tests for tuberculosis are unreliable

Jul 18, 2011

(AP) -- Widely used blood tests to detect tuberculosis are "dangerous" to patients because they are unreliable and can produce wrong results, the World Health Organization warned Sunday.

Recommended for you

Two expats die of MERS in Saudi commercial hub

11 hours ago

Two foreigners died of MERS in the Saudi city of Jeddah, the health ministry said Saturday, as fears rise over the spreading respiratory virus in the kingdom's commercial hub.

UAE reports 12 new cases of MERS

11 hours ago

Health authorities in the United Arab Emirates have announced 12 new cases of infection by the MERS coronavirus, but insisted the patients would be cured within two weeks.

Filipino tests negative for Middle East virus

23 hours ago

A Filipino nurse who tested positive for the Middle East virus has been found free of infection in a subsequent examination after he returned home, Philippine health officials said Saturday.

User comments